Esperite N.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
06 nov 2014 - 19:24
Statutaire naam
Esperite N.V.
Titel
Esperite N.V. convenes EGM to change auditor
Bericht
Esperite N.V. (Euronext: ESP, 'Esperite', or 'the Group'), the European leader in stem cells cryopreservation, now entering the fields of predictive medicine and translational regenerative medicine R&D, announces it is convening an extra-ordinary general meeting of shareholders ("EGM") to be held on Thursday 18 December 2014 to change its auditor.
On 14 May 2014 the shareholders meeting appointed KPMG Accountants N.V. as external auditor for a term of 1 year. Since the 14 May 2014 appointment, however, the Company has not been able to agree appropriate fees for the 2014 audit with KPMG. The fees proposed by KPMG represent a substantial increase in comparison with its previous audits of the Company's annual financial statements, with the Company disagreeing with the
Gerelateerde downloads
Datum laatste update: 09 januari 2026